MannKind Corp. (MNKD)

[Denise Chanterelle]

IMO, Mannkind investors should stop obsessing about the weekly prescription data and every minute-to-minute tick of the stock price. Sanofi's game plan is undoubtedly measured in years, and it has an impressive history of marketing new products, unlike all of us armchair experts who are disappointed with every weekly scripts figure.

With regards to the stock price, it's abundantly clear, from changes in the short interest, changes in the number of shares available for shorting on a daily basis, and changes in the interest rate being charged/paid to borrow shares, that the short sellers remain a major factor in the daily fluctuations. The day-to-day changes are of little consequence to investors, so letting the price changes affect your investment strategy (and blood pressure) makes very little sense.

True Longs already know what they have, as does Sanofi. Take it to the bank Crew! Aloha.